カテゴリー： QYResearch, 世界

世界の血管新生モジュレーター市場

QYResearchが発行した調査報告書（DATA909X03554）
◆英語タイトル：Global Angiogenesis Modulators Market Professional Survey Report 2019
◆商品コード：DATA909X03554
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月15日（※2024年版があります。お問い合わせください）
◆ページ数：111
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
※本調査レポートは、血管新生モジュレーターの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、血管新生阻害剤、血管新生刺激剤、アンジオジェニン、その他に、用途別には、乳がん、大腸がん、肺がん、前立腺がん、その他にセグメント区分し、血管新生モジュレーターの世界市場を分析しました。


・エグゼクティブ・サマリー
・血管新生モジュレーターの世界市場概要
・血管新生モジュレーターの製造コスト構成分析
・血管新生モジュレーターの開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・血管新生モジュレーターの地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・血管新生モジュレーターのセグメント分析（種類別）
（血管新生阻害剤、血管新生刺激剤、アンジオジェニン、その他）
・血管新生モジュレーターのセグメント分析（用途別）
（乳がん、大腸がん、肺がん、前立腺がん、その他）
・血管新生モジュレーターの主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Celgene Corporation (USA)、Eisai Co., Ltd. (Japan)、Amgen, Inc. (USA)、Genentech, Inc. (USA)、GlaxoSmithKline plc (UK)、Bayer Pharma AG (Germany)、Bionomics Ltd. (Australia)、CASI Pharmaceuticals, Inc. (USA)、AstraZeneca plc (UK)、Eli Lilly and Company (USA)、F.Hoffmann-La Roche AG (Switzerland)、）
・血管新生モジュレーターの市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Angiogenesis Modulators market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Angiogenesis Modulators volume and value at global level, regional level and company level. From a global perspective, this report represents overall Angiogenesis Modulators market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Angiogenesis Modulators in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Angiogenesis Modulators manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Celgene Corporation (USA)
Eisai Co., Ltd. (Japan)
Amgen, Inc. (USA)
Genentech, Inc. (USA)
GlaxoSmithKline plc (UK)
Bayer Pharma AG (Germany)
Bionomics Ltd. (Australia)
CASI Pharmaceuticals, Inc. (USA)
AstraZeneca plc (UK)
Eli Lilly and Company (USA)
F.Hoffmann-La Roche AG (Switzerland)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Angiogenesis Inhibitors
Angiogenesis Stimulators
Angiogenin
Others

Segment by Application
Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Angiogenesis Modulators
1.1 Definition of Angiogenesis Modulators
1.2 Angiogenesis Modulators Segment by Type
1.2.1 Global Angiogenesis Modulators Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Angiogenesis Inhibitors
1.2.3 Angiogenesis Stimulators
1.2.4 Angiogenin
1.2.5 Others
1.3 Angiogenesis Modulators Segment by Applications
1.3.1 Global Angiogenesis Modulators Consumption Comparison by Applications (2014-2025)
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Lung Cancer
1.3.5 Prostate Cancer
1.3.6 Others
1.4 Global Angiogenesis Modulators Overall Market
1.4.1 Global Angiogenesis Modulators Revenue (2014-2025)
1.4.2 Global Angiogenesis Modulators Production (2014-2025)
1.4.3 North America Angiogenesis Modulators Status and Prospect (2014-2025)
1.4.4 Europe Angiogenesis Modulators Status and Prospect (2014-2025)
1.4.5 China Angiogenesis Modulators Status and Prospect (2014-2025)
1.4.6 Japan Angiogenesis Modulators Status and Prospect (2014-2025)
1.4.7 Southeast Asia Angiogenesis Modulators Status and Prospect (2014-2025)
1.4.8 India Angiogenesis Modulators Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Angiogenesis Modulators
2.3 Manufacturing Process Analysis of Angiogenesis Modulators
2.4 Industry Chain Structure of Angiogenesis Modulators

3 Development and Manufacturing Plants Analysis of Angiogenesis Modulators
3.1 Capacity and Commercial Production Date
3.2 Global Angiogenesis Modulators Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Angiogenesis Modulators
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Angiogenesis Modulators Production and Capacity Analysis
4.2 Angiogenesis Modulators Revenue Analysis
4.3 Angiogenesis Modulators Price Analysis
4.4 Market Concentration Degree

5 Angiogenesis Modulators Regional Market Analysis
5.1 Angiogenesis Modulators Production by Regions
5.1.1 Global Angiogenesis Modulators Production by Regions
5.1.2 Global Angiogenesis Modulators Revenue by Regions
5.2 Angiogenesis Modulators Consumption by Regions
5.3 North America Angiogenesis Modulators Market Analysis
5.3.1 North America Angiogenesis Modulators Production
5.3.2 North America Angiogenesis Modulators Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Angiogenesis Modulators Import and Export
5.4 Europe Angiogenesis Modulators Market Analysis
5.4.1 Europe Angiogenesis Modulators Production
5.4.2 Europe Angiogenesis Modulators Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Angiogenesis Modulators Import and Export
5.5 China Angiogenesis Modulators Market Analysis
5.5.1 China Angiogenesis Modulators Production
5.5.2 China Angiogenesis Modulators Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Angiogenesis Modulators Import and Export
5.6 Japan Angiogenesis Modulators Market Analysis
5.6.1 Japan Angiogenesis Modulators Production
5.6.2 Japan Angiogenesis Modulators Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Angiogenesis Modulators Import and Export
5.7 Southeast Asia Angiogenesis Modulators Market Analysis
5.7.1 Southeast Asia Angiogenesis Modulators Production
5.7.2 Southeast Asia Angiogenesis Modulators Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Angiogenesis Modulators Import and Export
5.8 India Angiogenesis Modulators Market Analysis
5.8.1 India Angiogenesis Modulators Production
5.8.2 India Angiogenesis Modulators Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Angiogenesis Modulators Import and Export

6 Angiogenesis Modulators Segment Market Analysis (by Type)
6.1 Global Angiogenesis Modulators Production by Type
6.2 Global Angiogenesis Modulators Revenue by Type
6.3 Angiogenesis Modulators Price by Type

7 Angiogenesis Modulators Segment Market Analysis (by Application)
7.1 Global Angiogenesis Modulators Consumption by Application
7.2 Global Angiogenesis Modulators Consumption Market Share by Application (2014-2019)

8 Angiogenesis Modulators Major Manufacturers Analysis
8.1 Celgene Corporation (USA)
8.1.1 Celgene Corporation (USA) Angiogenesis Modulators Production Sites and Area Served
8.1.2 Celgene Corporation (USA) Product Introduction, Application and Specification
8.1.3 Celgene Corporation (USA) Angiogenesis Modulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Eisai Co., Ltd. (Japan)
8.2.1 Eisai Co., Ltd. (Japan) Angiogenesis Modulators Production Sites and Area Served
8.2.2 Eisai Co., Ltd. (Japan) Product Introduction, Application and Specification
8.2.3 Eisai Co., Ltd. (Japan) Angiogenesis Modulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Amgen, Inc. (USA)
8.3.1 Amgen, Inc. (USA) Angiogenesis Modulators Production Sites and Area Served
8.3.2 Amgen, Inc. (USA) Product Introduction, Application and Specification
8.3.3 Amgen, Inc. (USA) Angiogenesis Modulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Genentech, Inc. (USA)
8.4.1 Genentech, Inc. (USA) Angiogenesis Modulators Production Sites and Area Served
8.4.2 Genentech, Inc. (USA) Product Introduction, Application and Specification
8.4.3 Genentech, Inc. (USA) Angiogenesis Modulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 GlaxoSmithKline plc (UK)
8.5.1 GlaxoSmithKline plc (UK) Angiogenesis Modulators Production Sites and Area Served
8.5.2 GlaxoSmithKline plc (UK) Product Introduction, Application and Specification
8.5.3 GlaxoSmithKline plc (UK) Angiogenesis Modulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Bayer Pharma AG (Germany)
8.6.1 Bayer Pharma AG (Germany) Angiogenesis Modulators Production Sites and Area Served
8.6.2 Bayer Pharma AG (Germany) Product Introduction, Application and Specification
8.6.3 Bayer Pharma AG (Germany) Angiogenesis Modulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Bionomics Ltd. (Australia)
8.7.1 Bionomics Ltd. (Australia) Angiogenesis Modulators Production Sites and Area Served
8.7.2 Bionomics Ltd. (Australia) Product Introduction, Application and Specification
8.7.3 Bionomics Ltd. (Australia) Angiogenesis Modulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 CASI Pharmaceuticals, Inc. (USA)
8.8.1 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Production Sites and Area Served
8.8.2 CASI Pharmaceuticals, Inc. (USA) Product Introduction, Application and Specification
8.8.3 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 AstraZeneca plc (UK)
8.9.1 AstraZeneca plc (UK) Angiogenesis Modulators Production Sites and Area Served
8.9.2 AstraZeneca plc (UK) Product Introduction, Application and Specification
8.9.3 AstraZeneca plc (UK) Angiogenesis Modulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Eli Lilly and Company (USA)
8.10.1 Eli Lilly and Company (USA) Angiogenesis Modulators Production Sites and Area Served
8.10.2 Eli Lilly and Company (USA) Product Introduction, Application and Specification
8.10.3 Eli Lilly and Company (USA) Angiogenesis Modulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 F.Hoffmann-La Roche AG (Switzerland)

9 Development Trend of Analysis of Angiogenesis Modulators Market
9.1 Global Angiogenesis Modulators Market Trend Analysis
9.1.1 Global Angiogenesis Modulators Market Size (Volume and Value) Forecast 2019-2025
9.2 Angiogenesis Modulators Regional Market Trend
9.2.1 North America Angiogenesis Modulators Forecast 2019-2025
9.2.2 Europe Angiogenesis Modulators Forecast 2019-2025
9.2.3 China Angiogenesis Modulators Forecast 2019-2025
9.2.4 Japan Angiogenesis Modulators Forecast 2019-2025
9.2.5 Southeast Asia Angiogenesis Modulators Forecast 2019-2025
9.2.6 India Angiogenesis Modulators Forecast 2019-2025
9.3 Angiogenesis Modulators Market Trend (Product Type)
9.4 Angiogenesis Modulators Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Angiogenesis Modulators Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Angiogenesis Modulators
Table Global Angiogenesis Modulators Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Angiogenesis Modulators Production Market Share by Types in 2018
Figure Angiogenesis Inhibitors Product Picture
Figure Angiogenesis Stimulators Product Picture
Figure Angiogenin Product Picture
Figure Others Product Picture
Table Global Angiogenesis Modulators Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Angiogenesis Modulators Consumption Market Share by Applications in 2018
Figure Breast Cancer
Figure Colorectal Cancer
Figure Lung Cancer
Figure Prostate Cancer
Figure Others
Figure Global Angiogenesis Modulators Revenue (Million USD) (2014-2025)
Figure Global Angiogenesis Modulators Production (K MT) (2014-2025)
Figure North America Angiogenesis Modulators Market Size (Million USD) (2014-2025)
Figure Europe Angiogenesis Modulators Market Size (Million USD) (2014-2025)
Figure China Angiogenesis Modulators Market Size (Million USD) (2014-2025)
Figure Japan Angiogenesis Modulators Market Size (Million USD) (2014-2025)
Figure Southeast Asia Angiogenesis Modulators Market Size (Million USD) (2014-2025)
Figure India Angiogenesis Modulators Market Size (Million USD) (2014-2025)
Table Angiogenesis Modulators Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Angiogenesis Modulators in 2018
Figure Manufacturing Process Analysis of Angiogenesis Modulators
Figure Industry Chain Structure of Angiogenesis Modulators
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Angiogenesis Modulators Manufacturing Plants Distribution
Table Angiogenesis Modulators Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Angiogenesis Modulators Capacity (K MT) of Major Manufacturers (2014-2019)
Table Angiogenesis Modulators Production (K MT) of Major Manufacturers (2014-2019)
Table Angiogenesis Modulators Production Market Share of Major Manufacturers (2014-2019)
Figure Angiogenesis Modulators Production Share by Manufacturers in 2018
Table Angiogenesis Modulators Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Angiogenesis Modulators Revenue Market Share of Major Manufacturers (2014-2019)
Figure Angiogenesis Modulators Revenue Share by Manufacturers in 2018
Table Angiogenesis Modulators Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Angiogenesis Modulators Production by Regions 2014-2019 (K MT)
Table Global Angiogenesis Modulators Production Market Share by Regions 2014-2019
Figure Global Angiogenesis Modulators Production Market Share by Regions in 2018
Table Global Angiogenesis Modulators Revenue by Regions 2014-2019 (Million USD)
Table Global Angiogenesis Modulators Revenue Market Share by Regions 2014-2019
Figure Global Angiogenesis Modulators Revenue Market Share by Regions in 2018
Table Global Angiogenesis Modulators Consumption by Regions 2014-2019 (K MT)
Table Global Angiogenesis Modulators Consumption Market Share by Regions 2014-2019
Figure North America Angiogenesis Modulators Production Growth Rate 2014-2019 (K MT)
Figure North America Angiogenesis Modulators Revenue Growth Rate 2014-2019 (Million USD)
Table North America Angiogenesis Modulators Production, Consumption Import and Export (K MT)
Figure Europe Angiogenesis Modulators Production Growth Rate 2014-2019 (K MT)
Figure Europe Angiogenesis Modulators Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Angiogenesis Modulators Production, Consumption Import and Export (K MT)
Figure China Angiogenesis Modulators Production Growth Rate 2014-2019 (K MT)
Figure China Angiogenesis Modulators Revenue Growth Rate 2014-2019 (Million USD)
Table China Angiogenesis Modulators Production, Consumption Import and Export (K MT)
Figure Japan Angiogenesis Modulators Production Growth Rate 2014-2019 (K MT)
Figure Japan Angiogenesis Modulators Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Angiogenesis Modulators Production, Consumption Import and Export (K MT)
Figure Southeast Asia Angiogenesis Modulators Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia Angiogenesis Modulators Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Angiogenesis Modulators Production, Consumption Import and Export (K MT)
Figure India Angiogenesis Modulators Production Growth Rate 2014-2019 (K MT)
Figure India Angiogenesis Modulators Revenue Growth Rate 2014-2019 (Million USD)
Table India Angiogenesis Modulators Production, Consumption Import and Export (K MT)
Figure Global Consumption Angiogenesis Modulators Market Share by Application (2014-2019)
Figure Global Value (Consumption) Angiogenesis Modulators Market Share by Application (2014-2019)
Table Celgene Corporation (USA) Angiogenesis Modulators Production Sites and Area Served
Table Celgene Corporation (USA) Angiogenesis Modulators Product Introduction, Application and Specification
Table Celgene Corporation (USA) Angiogenesis Modulators Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Celgene Corporation (USA) Angiogenesis Modulators Production Growth Rate (2014-2019)
Table Celgene Corporation (USA) Angiogenesis Modulators Production Market Share (2014-2019)
Figure Celgene Corporation (USA) Angiogenesis Modulators Revenue Market Share (2014-2019)
Table Celgene Corporation (USA) Angiogenesis Modulators Main Business and Markets Served
Table Eisai Co., Ltd. (Japan) Angiogenesis Modulators Production Sites and Area Served
Table Eisai Co., Ltd. (Japan) Angiogenesis Modulators Product Introduction, Application and Specification
Table Eisai Co., Ltd. (Japan) Angiogenesis Modulators Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Eisai Co., Ltd. (Japan) Angiogenesis Modulators Production Growth Rate (2014-2019)
Table Eisai Co., Ltd. (Japan) Angiogenesis Modulators Production Market Share (2014-2019)
Figure Eisai Co., Ltd. (Japan) Angiogenesis Modulators Revenue Market Share (2014-2019)
Table Eisai Co., Ltd. (Japan) Angiogenesis Modulators Main Business and Markets Served
Table Amgen, Inc. (USA) Angiogenesis Modulators Production Sites and Area Served
Table Amgen, Inc. (USA) Angiogenesis Modulators Product Introduction, Application and Specification
Table Amgen, Inc. (USA) Angiogenesis Modulators Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Amgen, Inc. (USA) Angiogenesis Modulators Production Growth Rate (2014-2019)
Table Amgen, Inc. (USA) Angiogenesis Modulators Production Market Share (2014-2019)
Figure Amgen, Inc. (USA) Angiogenesis Modulators Revenue Market Share (2014-2019)
Table Amgen, Inc. (USA) Angiogenesis Modulators Main Business and Markets Served
Table Genentech, Inc. (USA) Angiogenesis Modulators Production Sites and Area Served
Table Genentech, Inc. (USA) Angiogenesis Modulators Product Introduction, Application and Specification
Table Genentech, Inc. (USA) Angiogenesis Modulators Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Genentech, Inc. (USA) Angiogenesis Modulators Production Growth Rate (2014-2019)
Table Genentech, Inc. (USA) Angiogenesis Modulators Production Market Share (2014-2019)
Figure Genentech, Inc. (USA) Angiogenesis Modulators Revenue Market Share (2014-2019)
Table Genentech, Inc. (USA) Angiogenesis Modulators Main Business and Markets Served
Table GlaxoSmithKline plc (UK) Angiogenesis Modulators Production Sites and Area Served
Table GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Introduction, Application and Specification
Table GlaxoSmithKline plc (UK) Angiogenesis Modulators Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table GlaxoSmithKline plc (UK) Angiogenesis Modulators Production Growth Rate (2014-2019)
Table GlaxoSmithKline plc (UK) Angiogenesis Modulators Production Market Share (2014-2019)
Figure GlaxoSmithKline plc (UK) Angiogenesis Modulators Revenue Market Share (2014-2019)
Table GlaxoSmithKline plc (UK) Angiogenesis Modulators Main Business and Markets Served
Table Bayer Pharma AG (Germany) Angiogenesis Modulators Production Sites and Area Served
Table Bayer Pharma AG (Germany) Angiogenesis Modulators Product Introduction, Application and Specification
Table Bayer Pharma AG (Germany) Angiogenesis Modulators Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Bayer Pharma AG (Germany) Angiogenesis Modulators Production Growth Rate (2014-2019)
Table Bayer Pharma AG (Germany) Angiogenesis Modulators Production Market Share (2014-2019)
Figure Bayer Pharma AG (Germany) Angiogenesis Modulators Revenue Market Share (2014-2019)
Table Bayer Pharma AG (Germany) Angiogenesis Modulators Main Business and Markets Served
Table Bionomics Ltd. (Australia) Angiogenesis Modulators Production Sites and Area Served
Table Bionomics Ltd. (Australia) Angiogenesis Modulators Product Introduction, Application and Specification
Table Bionomics Ltd. (Australia) Angiogenesis Modulators Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Bionomics Ltd. (Australia) Angiogenesis Modulators Production Growth Rate (2014-2019)
Table Bionomics Ltd. (Australia) Angiogenesis Modulators Production Market Share (2014-2019)
Figure Bionomics Ltd. (Australia) Angiogenesis Modulators Revenue Market Share (2014-2019)
Table Bionomics Ltd. (Australia) Angiogenesis Modulators Main Business and Markets Served
Table CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Production Sites and Area Served
Table CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product Introduction, Application and Specification
Table CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Production Growth Rate (2014-2019)
Table CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Production Market Share (2014-2019)
Figure CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Revenue Market Share (2014-2019)
Table CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Main Business and Markets Served
Table AstraZeneca plc (UK) Angiogenesis Modulators Production Sites and Area Served
Table AstraZeneca plc (UK) Angiogenesis Modulators Product Introduction, Application and Specification
Table AstraZeneca plc (UK) Angiogenesis Modulators Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table AstraZeneca plc (UK) Angiogenesis Modulators Production Growth Rate (2014-2019)
Table AstraZeneca plc (UK) Angiogenesis Modulators Production Market Share (2014-2019)
Figure AstraZeneca plc (UK) Angiogenesis Modulators Revenue Market Share (2014-2019)
Table AstraZeneca plc (UK) Angiogenesis Modulators Main Business and Markets Served
Table Eli Lilly and Company (USA) Angiogenesis Modulators Production Sites and Area Served
Table Eli Lilly and Company (USA) Angiogenesis Modulators Product Introduction, Application and Specification
Table Eli Lilly and Company (USA) Angiogenesis Modulators Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Eli Lilly and Company (USA) Angiogenesis Modulators Production Growth Rate (2014-2019)
Table Eli Lilly and Company (USA) Angiogenesis Modulators Production Market Share (2014-2019)
Figure Eli Lilly and Company (USA) Angiogenesis Modulators Revenue Market Share (2014-2019)
Table Eli Lilly and Company (USA) Angiogenesis Modulators Main Business and Markets Served
Table F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Production Sites and Area Served
Figure Global Angiogenesis Modulators Production (K MT) Growth Rate Forecast 2019-2025
Figure Global Angiogenesis Modulators Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Angiogenesis Modulators Sales Price (USD/MT) Forecast 2019-2025
Figure North America Angiogenesis Modulators Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America Angiogenesis Modulators Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Angiogenesis Modulators Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe Angiogenesis Modulators Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Angiogenesis Modulators Production Growth Rate Forecast 2019-2025 (K MT)
Figure China Angiogenesis Modulators Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Angiogenesis Modulators Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan Angiogenesis Modulators Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Angiogenesis Modulators Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia Angiogenesis Modulators Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Angiogenesis Modulators Production Growth Rate Forecast 2019-2025 (K MT)
Figure India Angiogenesis Modulators Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of Angiogenesis Modulators by Type (2019-2025)
Table Global Consumption (K MT) of Angiogenesis Modulators by Application (2019-2025)
Table Angiogenesis Modulators Distributors List
Table Angiogenesis Modulators Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Celgene Corporation (USA)、Eisai Co., Ltd. (Japan)、Amgen, Inc. (USA)、Genentech, Inc. (USA)、GlaxoSmithKline plc (UK)、Bayer Pharma AG (Germany)、Bionomics Ltd. (Australia)、CASI Pharmaceuticals, Inc. (USA)、AstraZeneca plc (UK)、Eli Lilly and Company (USA)、F.Hoffmann-La Roche AG (Switzerland)、

【免責事項】
https://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の血管新生モジュレーター市場(Global Angiogenesis Modulators Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • HIV関連リポジストロフィー症候群治療の世界市場：規模・現状・予測
  • 世界のサバ産業：成長傾向・競合分析
  • 世界のリチウム金属二次電池産業：成長傾向・競合分析
  • 世界のオーディオビジュアルケーブル産業：成長傾向・競合分析
  • 世界のトラディショナル・バーチェア市場
  • 世界の信号トランス市場
  • 世界のポータブル加湿器市場
  • 世界のナノろ過膜市場
  • 世界のN,N-ジエチルエタノールアミン市場
  • 世界の等温核酸増幅技術（INAAT）市場
  • 世界のガラス瓶型市場
  • 世界のDPCセラミック基板市場
  • 世界の自動車用炭素繊維市場
  • 世界のアルミ鋳造製品市場
  • 世界のオールマウンテンスキー市場